FILE:FMC/FMC-8K-20040609103704.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
 
 
 
 
 
 
ITEM 9.     Regulation FD Disclosure.
 
On October 21, 2002, FMC Corporation ("FMC") executed a $500 million Credit Agreement that included a $250 million revolving credit facility and $250 million term loan facility. As of March 31, 2004 there was $243 million aggregate principal amount of term loans outstanding. FMC is seeking the consent of its lenders to reduce the interest rate margin under its term loan facility. On June 8, 2004, Thomas C. Deas Jr., Vice President and Treasurer, made the attached presentation to the company's senior lenders. Slides used in his presentation at the conference call are included hereto as an exhibit. These slides may also be accessed at the company's website () and will be available for a period of at least thirty days.
www.fmc.com
 
This report is not deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Date: June 9, 2004
 
 

Exhibit 99.1
 
Exhibit 99.1
FMC Corporation
Presentation to Senior Lenders
June 8, 2004
PUBLIC VERSION
 
Agenda
Performance Update and Outlook
Transaction Overview
Public Q&A
Financial Projections
Private Q&A
1
 
Performance Update and Outlook
Thomas C. Deas, Jr. Vice President & Treasurer
 
Disclaimer
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
These slides and the accompanying presentation contain "forward-looking statements" that represent management's best judgment as of the date hereof based on information currently available. Actual results of the Company may differ materially from those contained in the forward-looking statements.
Additional information concerning factors that may cause results to materially differ from those in the forward-looking statements is contained in the Company's periodic reports filed under the Securities Exchange Act of 1934, as amended.
The Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.
3
 
FMC Corporation
Diversified chemical company with leading market positions in industrial, consumer and agricultural markets globally
($            in millions; LTM Results through 3/31/04)
FMC
Sales(1): $ 1,993.1
Adjusted EBITDA(2) : 331.3
Adj. EBITDA Margin: 16.6%
Industrial Chemicals
Sales: $789.1
Specialty Chemicals
Sales: $523.6
Agricultural Products
Sales: $685.0
(1) Segment figures exclude $4.6 million in eliminations.
(2) Adjusted EBITDA (Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization) is the sum of Income from continuing operations before equity earnings in affiliates, minority interests, interest income and expense, income taxes and cumulative effect of change in accounting principle and Depreciation and Amortization less Restructuring and other charges (gains).
See Appendix for reconciliation to GAAP 4
 
FMC's Strengths
Leading market positions
Global presence
Diversified business mix and high-quality customer base
Diversified and integrated cost structure
Focused R&D and strong applications expertise
Proven management with extensive industry experience
5
 
Operating Performance: 1st Quarter 2004
Revenue up 17% *
 Higher revenue in all three business segments
Adjusted EBITDA up 16% *
 Agricultural Products up
 Specialty Chemicals flat
 Industrial Chemicals weaker
Free cash flow up $30 million *
 Working capital focus
 Capital spending less than D&A
* Compared to the 1st quarter of 2003.
6
 
Agricultural Products: 1Q 2004 Performance
Robust Brazilian crop market and focused strategy drives growth
Sales up 35%, segment earnings up four-fold
Sales increase driven by:
 Broad-based growth across insecticides and herbicides
 Two-thirds of the increase from strong performance in Latin America
 Improved Brazilian farm economy and heavy pest pressures
Segment earnings growth driven by:
 Higher sales
 Improved product mix
 Lower costs
Note: All comparisons are against the first quarter of 2003
7
 
Specialty Chemicals: 1Q 2004 Performance
Growth strategies in key franchises deliver strong performance
Sales up 6%, segment earnings essentially unchanged
BioPolymer businesses drive healthy sales increase
 Stronger microcrystalline cellulose sales for the pharmaceutical markets in Europe and the U.S.
 Higher carrageenan sales into the personal care and food ingredients markets
Strong lithium sales in the battery market as well as favorable currency translation
Segment earnings flat primarily due to higher raw materials costs
Note: All comparisons are against the first quarter of 2003
8
 
Industrial Chemicals: 1Q 2004 Performance
Signs of recovery despite higher freight and energy costs
Sales up 10%, segment earnings down 32%
Strong growth from Foret
 Higher volumes and selling prices for STPP and peroxygens
 Favorable foreign currency translation
Improved soda ash volumes and higher domestic selling prices
were offset by:
 Lower export selling prices
 Unfavorable product mix in domestic peroxygens
Improvement in affiliate earnings due to the benefit of the Astaris
restructuring
Segment earnings down due to:
 Higher freight and energy costs
 Lower soda ash export selling prices
Note: All comparisons are against the first quarter of 2003
 
1Q 2004 Financial Performance
1st Quarter 1st Quarter LTM
($            in millions) 2003 2003 2004 03/31/04
Revenue $ 1,921.4 $ 434.0 $ 505.7 $ 1,993.1 Income from Operations(1) 196.6 31.9 39.3 204.0
D&A 124.6 30.5 33.2 127.3 Adjusted EBITDA $ 321.2 $ 62.4 $ 72.5 $ 331.3
Margin 16.7% 14.4% 14.3% 16.6% Interest Expense, Net $ 92.2 $ 25.3 $ 20.4 $ 87.3
Capital Expenditures 87.0 17.1 13.3 83.2
Debt Balance $ 1,050.2 $ 1,122.2
Bank Debt(2)/Adjusted EBITDA 0.8x 1.0x
Net Debt(3)/Adjusted EBITDA 3.1x 3.3x
Adj. EBITDA/Interest Expense 3.5x 3.8x
(Adj. EBITDA-CapEx)/Int. Exp. 2.5x 2.8x
(1) Excludes restructuring, other charges and gains. Income from Operations is defined as Income from Operations before equity in loss (earnings) of affiliates, minority interests, interest expense, net and income taxes.
(2) Includes borrowings under foreign lines.
(3) Net Debt is net of $43.3 million of cash collateralizing $41.0 million of variable rate industrial and pollution control revenue bonds.
10
 
Current Capitalization
($            in millions) 03/31/03 03/31/04
Cash and Cash Equivalents $ 60.0 $ 65.1
Restricted Cash Account 259.3 136.7
Balance Sheet Debt
Foreign Bank Borrowings $ 44.0 $ 22.9
Senior Secured Revolving Credit due 2005 87.0 67.0
Senior Secured Term Loan due 2007 245.3 239.3
Total Bank Debt $ 376.3 $ 329.2
Pollution Control and IR Bonds due 07-'32 $ 220.4 $ 218.7
10.25% Senior Secured Notes due 2009 350.9 351.5
Other Public Domestic Debt 370.4 222.8
Total Debt $ 1,318.0 $ 1,122.2
Debt, net of all cash $ 998.7 $ 920.4
11
 
Strong Liquidity Position
03/31/04
($            in millions)
Revolving Credit Facility $ 250.0
Less: Amount Drawn (67.0)
Outstanding L/C's (2.6)
Revolving Credit Availability $ 180.4
Plus: Unrestricted Cash 65.1
Total Committed Liquidity $ 245.5
Plus: Undrawn Advised Foreign Credit Lines 101.0
Total Liquidity $ 346.5
12
 
2004 Outlook
Great progress towards our strategic objectives in 2004
Strong earnings growth in Agricultural Products
 Higher sales due to Latin America's strong 1st quarter performance
 Improved product mix and lower costs
Solid earnings in Specialty Chemicals
 Higher sales in pharmaceutical, food ingredients and battery markets
 Increased sales somewhat offset by higher raw material costs and unfavorable product mix
50% earnings growth in Industrial Chemicals
 Selling price improvements in most products
 Improvement at Astaris
 Increased sales to a certain extent offset by higher energy costs
Debt levels
 Net debt reduction $20-40 million
13
 
Create Greater Financial Flexibility
Despite Astaris restructuring, FMC is on track to reduce $300 million of debt by the end of 2006
Cash Flow Highlights 2004 2005 2006 2007
Adjusted EBITDA* ~$ 331 Increasing
Pre-Tax Interest** 84 Decreasing A
Capital Expenditures 90 Relatively Flat A
Cash Taxes 15 Relatively Flat A
Legacy Environmental 25 ~25 ~25 ~25
Restructuring (Pocatello) 35 <10 <10 <10
Astaris Keepwells 40 0 0 0
Total Legacy Outflows 100 <35 <35 <35
* Adjusted EBITDA for the period ending LTM 3/31/04 was $331 million. No explicit guidance has been provided for
Adjusted EBITDA for full-year 2004.
** Includes $82 million of GAAP interest expense and $2 million of affiliate interest expense.
14
 
Strategic Objectives
Realize the operating leverage inherent within FMC
 Double-digit growth in earnings before restructuring and other charges
 Industrial Chemicals recovery to add earnings of over $1 per share
Create greater financial flexibility
 Net debt reduction of $300 million by 2006
 Regain an investment grade credit rating
Focus the portfolio on higher growth businesses
 Manage Specialty Chemicals and Agricultural Products for growth
 Manage Industrial Chemicals for cash
 Divest any business that cannot sustain its cost of capital
 Improve ROIC to 12 percent minimum by 2006
15
 
Transaction Overview
Michael Mauer
Managing Director, Citigroup
 
Transaction Overview
Term Loan B
Borrower: FMC Corporation
Guarantors: Same as existing
Amount: $243.0 million
Ratings: BBB-/Ba1
Pricing: L + 175 bps
Security: Same as existing
Maturity: Same as existing
Covenants: Same as existing
 
Timetable
June 2004
S M T W T F S
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30
Event Date
Launch Amendment in Marketplace June 7
Conference Call with Lenders June 8
Commitments Due June 15
Closing June 21
18
 
FMC Corporation
Public Q&A
 
Appendix
 
Adjusted EBITDA Calculation
1st Quarter 1st Quarter LTM ($            in millions) 2003 2003 2004 03/31/04 Income (loss) from continuing operations before income taxes $38.0 $2.4 $7.2 $42.8 Add: D&A 124.6 30.5 33.2 127.3 Minority interest 2.9 0.7 0.7 2.9 Interest expense, net 92.2 25.3 20.4 87.3 Deduct: Equity earnings (loss) of affiliates (68.6) (3.5) (9.7) (74.8) EBITDA $326.3 $62.4 $71.2 $335.1 Special Items: Restructuring and other charges (gains) (5.1) 1.3 (3.8) Adjusted EBITDA $321.2 $62.4 $72.5 $331.3
21


